Lizzie Ngo joined Flagship Pioneering as an associate after completing the firm's Fellows Program in 2018. At Flagship, Lizzie works as part of a venture creation team, exploring and generating innovative ideas to drive development of technology and business components that will lead to breakthrough startups.
Prior to Flagship, Lizzie was a postdoctoral associate at MIT, where she worked with the NSF-funded MIT Innovation Corps to commercialize an anti-cancer drug screening platform based on her academic work. Lizzie completed her doctorate in biological engineering under the supervision of Professors Leona Samson and Bevin Engelward at MIT, developing high-throughput assays for quantitation of DNA damage and repair and applying them to assess individuals’ cancer susceptibility. Lizzie’s graduate work resulted in publication in several peer-reviewed journals, a pending patent, and multiple awards from the Environmental Mutagenesis & Genomics Society and the MIT Center of Environmental Health Sciences.
In addition to her research, Lizzie led a team of five to compete in the semi-finals of the Sloan Healthcare Innovation Prize. She was also an organizer and served as a mentor for MIT and Harvard-funded BiomedStartup course, a boot camp for entrepreneurial scientists and M.B.A. students who want to start their own biotechs. She also served as the student co-chair of the New Technology committee at EMGS.
In addition to her Ph.D. from MIT, Lizzie received her B.A. in genetics with a minor in mathematics from Rutgers University, where she graduated summa cum laude and was named the top graduating student in her class. While pursuing her Bachelor’s degree, she worked with Dr. Jody Hey to use early DNA sequencing data to model the likelihood of inter-breeding between modern humans and Neanderthals.